Yangjianchen Xu

Assistant Professor

University of Waterloo

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yangjianchen Xu is an Assistant Professor at the University of Waterloo, Canada. His research focuses on biostatistics, particularly related to the analysis of COVID-19 vaccination and infection outcomes, utilizing models such as the Cox Proportional Hazards Model and multivariate panel count data. Recent articles authored by Dr. Xu explore the effectiveness and durability of COVID-19 vaccines and their impact on different populations, including children and individuals living with HIV.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (1)

Xueying YANG

Research Assistant Professor

University of South Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yangjianchen Xu

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Effects of COVID-19 vaccination and past SARS-CoV-2 infection on subsequent COVID-19 infection in people with HIV

Checking the Cox Proportional Hazards Model with Interval-Censored Data

Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death

Proportional rates models for multivariate panel count data

Proportional rates models for multivariate panel count data

Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants

Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study

Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study

Durability of Bivalent Boosters against Omicron Subvariants

Durability of Bivalent Boosters against Omicron Subvariants

Effectiveness of Bivalent Boosters against Severe Omicron Infection

Effectiveness of Bivalent Boosters against Severe Omicron Infection

Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age

Collaborators (1)

Xueying YANG

Make your next move.